Tue. Jul 29th, 2025

The Malaysian Medical Association (MMA) has expressed concerns over the proposed amendment to the Poisons Act, which they believe may have far-reaching consequences on the medical community. The MMA has urged the Ministry of Health (MOH) to halt the amendment, citing potential risks to patient care and the practice of medicine. The proposed amendment aims to regulate the use of certain medications and substances, but the MMA argues that it may lead to unnecessary restrictions on medical practitioners. The association claims that the amendment may limit the availability of certain medications, leading to a shortage of essential drugs. This, in turn, may compromise patient care and outcomes. The MMA has also raised concerns about the potential impact on medical research and development, as the amendment may restrict the use of certain substances in clinical trials. Furthermore, the association believes that the amendment may lead to increased bureaucracy and red tape, making it more difficult for medical practitioners to access the medications they need. The MMA has called on the MOH to engage in further consultation with the medical community before proceeding with the amendment. The association has also suggested that the MOH consider alternative solutions, such as education and training programs, to address concerns about the misuse of certain substances. The proposed amendment has sparked debate among medical professionals, with some arguing that it is necessary to prevent the misuse of certain medications, while others believe that it may have unintended consequences. The MMA has emphasized the need for careful consideration and consultation to ensure that any changes to the Poisons Act do not harm patient care or the practice of medicine. The association has also highlighted the importance of balancing regulation with the need for medical practitioners to have access to the medications and substances they need to provide effective care. In addition, the MMA has pointed out that the proposed amendment may have implications for the country’s healthcare system as a whole, and that it is essential to consider the potential impact on healthcare outcomes and patient safety. The MOH has yet to respond to the MMA’s concerns, but the association has vowed to continue advocating for the interests of medical practitioners and patients. The debate over the proposed amendment is likely to continue, with the MMA and other medical organizations pushing for a more nuanced approach to regulation. As the situation unfolds, it remains to be seen how the MOH will address the concerns of the medical community and balance the need for regulation with the need for effective patient care.

Source